3rd Covid wave: 1,000 Ayurveda practitioners to discuss treatment protocol for Covid cases among kids businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
The head of the government-run All India Institute of Ayurveda (AIIA) has said the facility has successfully treated at least 600 Covid patients by implementing both the systems of medicine.
Top ayurveda institute incorporates allopathy, modern tech; successfully treats 600 Covid patients
SECTIONS
Last Updated: Jun 02, 2021, 05:40 PM IST
Share
Synopsis Pure ayurvedic treatment was provided to more than 94 percent of the patients, but allopathy was used wherever required as per the guidelines of the Indian Council of Medical Research. That s the reason for our success. We have adopted a holistic and integrated approach, Prof Nesari, an MD in Ayurvedic Pharmacology, told.
Agencies
Prof Tanuja Nesari said a holistic approach and the integration of ayurveda, allopathy and modern diagnostic technology made it possible.
Amid a controversy over Yoga guru Ramdev s remarks on allopathy and doctors, the head of the government-run All India Institute of Ayurveda (AIIA) has said the facility has successfully treated at least 600 Covid patients by implementing both the systems of medicine.
Amid a controversy over Yoga guru Ramdev's remarks on allopathy and doctors, the head of the government-run All India Institute of Ayurveda said the facility has successfully treated at least 600 Covid patients by implementing both the systems.
Neem formulation 55% effective in preventing Covid, says Nisarga Biotech
May 20, 2021
Nisarga Biotech Pvt Ltd, which offers 40 natural therapeutic products for chronic diseases, recently launched Nisarga Neem Capsules that has proven to be an effective preventive remedy for Covid-19 after its recently concluded clinical trials in April 2021.
BusinessLine caught up with the Satara, Maharashtra headquartered company’s founder and CEO Girish Soman, to find out more. Excerpts:
What led to the creation of Nisarga’s neem capsules as a prophylactic for Covid-19?
Nisarga’s clinical trial was based on its patent-pending neem leaf extract, well researched for six years in pre-clinical studies with a reputed research institute in the US and toxicity studies completed as per the USFDA norms. Neem has been reported to exert anti-inflammatory, antibacterial/antiviral and antioxidant effects in our research as well as previously conducted anti-docking studies making it a potential p